Gilbert syndrome: An autosomal recessive inherited disorder characterized by unconjugated hyperbilirubinemia, resulting in harmless intermittent jaundice.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
272 |
4. Check minimum number of eventsNone |
272 |
5. Include endpointsNone |
272 |
6. Filter based on genotype QC (FinnGen only) |
272 |
Control definitions (FinnGen only)
- Control exclude
- E4_METABOLIA
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- E80
- Name in latin
- Syndroma Gilbert
Similar endpoints
↥List of similar endpoints to
Gilbert syndrome
based on the number of shared cases.
Similar with more cases:
- Disorders of porphyrin and bilirubin metabolism
- Metabolic disorders
- Endocrine, nutritional and metabolic diseases
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2080 | 758 | 1310 |
| Only index persons | 1976 | 732 | 1244 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.03 | 0.02 | 0.04 |
| Only index persons | 0.04 | 0.03 | 0.05 |
| Median age at first event (years) | |||
| Whole population | 35.03 | 37.47 | 33.51 |
| Only index persons | 34.37 | 36.95 | 32.86 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 272 | 113 | 159 |
| Unadjusted period prevalence (%) | 0.06 | 0.04 | 0.07 |
| Median age at first event (years) | 41.55 | 39.84 | 42.76 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 244
- Matched controls
- 2440
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
E80.4
ICD-10 Finland
Gilbert syndrome
+∞
294.0
219
*
R17
ICD-10 Finland
Hyperbilirubinaemia, with or without jaundice, not elsewhere classified
42.4
24.6
30
8
27350
ICD-8 Finland
Other and unspecified congenital disorders of metabolism, Icterus intermittens juvenilis
+∞
16.9
16
*
2774A
ICD-9 Finland
Other and unspecified disorders of metabolism, Disorders of bilirubin excretion[SYNDROMA GILBERT]
+∞
13.7
13
*
57308
ICD-8 Finland
Other diseases of liver, Alii definiti
+∞
11.5
11
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.7
11.5
105
534
A06AC01
ATC
ispaghula (psylla seeds); oral
3.0
9.6
61
244
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
4.1
8.6
33
89
E80.7
ICD-10 Finland
Disorder of bilirubin metabolism, unspecified
+∞
8.4
8
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.5
8.4
74
357
Z01.8
ICD-10 Finland
Other specified special examinations
2.5
7.0
62
296
A02BC02
ATC
pantoprazole; systemic
2.0
6.2
142
1012
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
185
1051
3.38
19.92
7.8
6.7
umol/l
31.4
11.3
17.24
178
1001
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
37
75
5.55
17.93
1.9
2.0
g/l
0.9
1.4
3.12
32
64
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
217
1587
2.82
11.05
9.3
7.4
u/l
76.0
77.1
0.18
208
1494
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
55
210
3.03
11.00
5.6
4.5
u/l
205.4
235.0
2.35
50
204
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
122
710
2.30
10.12
3.8
3.3
u/l
32.2
30.3
0.40
117
678
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
23
54
4.56
9.32
1.3
1.8
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
204
1516
2.38
8.88
4.5
3.9
mm/h
7.1
9.9
3.60
194
1416
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
105
623
2.12
7.87
2.8
2.3
u/l
60.9
55.5
1.51
98
584
(3002030) Lymphocytes/100 leukocytes in Blood
151
1034
2.03
7.57
6.4
6.1
%
29.0
28.6
0.18
143
977
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
202
1543
2.20
7.49
4.0
3.1
u/l
47.4
43.2
0.34
196
1471
(42870588) Differential panel, method unspecified - Blood
111
690
2.03
7.21
6.7
5.9
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
36
137
2.88
7.15
2.8
3.3
e9/l
77.2
67.5
0.84
29
108
(3018010) Neutrophils/100 leukocytes in Blood
147
1021
1.96
6.83
6.1
5.9
%
56.4
56.6
0.09
140
968
(3032080) INR in Blood by Coagulation assay
111
703
1.98
6.74
6.0
6.5
inr
1.1
1.2
0.46
25
199
(3007164) IgA [Mass/volume] in Serum or Plasma
79
448
2.08
6.48
1.7
1.3
g/l
1.9
2.5
3.19
61
274
(3019069) Monocytes/100 leukocytes in Blood
143
997
1.92
6.44
6.6
6.4
%
8.9
8.6
0.33
138
944
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
132
900
1.91
6.33
5.2
6.5
mmol/l
1.2
1.2
1.10
118
779
(3001122) Ferritin [Mass/volume] in Serum or Plasma
129
880
1.89
6.12
3.0
2.6
ug/l
153.7
122.8
1.06
123
827
(3024561) Albumin [Mass/volume] in Serum or Plasma
120
801
1.89
6.08
4.8
4.6
g/l
38.2
36.4
3.87
114
759
(3006504) Eosinophils/100 leukocytes in Blood
140
990
1.85
5.85
6.5
6.1
%
2.7
2.9
0.41
135
924
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
81
484
1.96
5.66
1.3
1.3
u/ml
0.8
1.4
0.77
22
123
(3019198) Lymphocytes [#/volume] in Blood
151
1107
1.82
5.49
6.4
6.0
e9/l
1.8
1.8
0.69
137
986
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
8
5
16.41
5.44
1.6
2.6
u/l
169.6
237.8
—
8
5
(3013115) Eosinophils [#/volume] in Blood
150
1107
1.79
5.25
6.7
6.5
e9/l
0.2
0.2
1.04
134
979
(3022096) Basophils/100 leukocytes in Blood
135
966
1.79
5.24
6.7
6.1
%
0.7
0.7
0.39
130
907
(3019225) pH of Specimen
37
169
2.38
5.09
3.4
4.3
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
249
2188
2.63
4.99
14.6
11.7
mg/l
17.5
23.1
2.94
190
1676
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
192
1538
1.84
4.98
3.8
3.6
pmol/l
14.9
14.7
0.44
177
1415
(3037522) Nuclear Ab [Titer] in Serum
54
295
2.04
4.79
1.4
1.4
titre
826.7
434.1
—
9
61
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
223
1884
2.02
4.79
4.6
4.1
mu/l
1.9
1.9
0.03
209
1747
(3001604) Monocytes [#/volume] in Blood
144
1069
1.74
4.77
6.5
6.0
e9/l
0.6
0.6
0.12
126
925
(3006315) Basophils [#/volume] in Blood
144
1070
1.73
4.75
6.5
6.0
e9/l
0.0
0.0
0.08
127
931
(3022145) Colonoscopy Study observation
44
229
2.10
4.43
1.2
1.3
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
173
1371
1.72
4.36
4.6
3.6
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
10
22
4.68
4.34
1.4
1.2
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
75
473
1.81
4.31
2.4
3.0
ng/l
685.5
885.3
0.43
66
392
(3017143) Hepatitis C virus Ab [Presence] in Serum
53
301
1.94
4.20
1.5
1.6
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
47
256
2.01
4.19
1.2
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
72
459
1.77
3.96
1.7
1.6
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
114
825
1.66
3.94
5.3
6.0
mmol/l
1.2
1.2
3.98
108
769
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
11
29
3.91
3.84
1.3
1.3
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
97
678
1.67
3.81
3.9
3.2
e6/l
46.8
45.2
0.02
68
476
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
190
1577
1.68
3.72
3.6
3.3
—
—
—
0
0
(3013512) EKG study
80
536
1.70
3.66
4.3
3.0
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
68
438
1.74
3.58
1.8
1.8
mg/l
1.1
1.1
0.05
40
334
(3006922) Hepatitis E virus Ab [Presence] in Serum
7
10
7.15
3.38
1.0
1.0
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
152
1214
1.57
3.31
10.8
10.2
e9/l
3.8
3.9
0.33
132
1064
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
102
746
1.59
3.24
2.1
2.3
nmol/l
78.3
73.4
1.08
97
685
(3048689) Calprotectin [Mass/mass] in Stool
47
280
1.82
3.20
2.7
2.4
ug/g
81.3
101.1
0.30
41
231
(40768804) Tissue Pathology biopsy report
108
807
1.56
3.10
2.3
2.0
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
228
2025
1.78
3.08
12.6
10.5
ml/min/173m2
85.8
87.4
0.59
202
1630
(3017732) Neutrophils [#/volume] in Blood
28
142
2.08
3.03
1.7
2.4
e9/l
3.8
4.0
0.22
22
118
(3002582) Erythrocytes [#/volume] in Urine
82
579
1.60
2.99
3.5
2.8
e6/l
11.0
184.8
0.89
61
441
(3010813) Leukocytes [#/volume] in Blood
264
2498
2.93
2.95
21.5
17.4
e9/l
6.2
6.5
2.10
259
2430
(3026361) Erythrocytes [#/volume] in Blood
264
2497
2.95
2.94
21.5
17.3
e12/l
4.6
4.6
0.00
259
2429
(3049717) Cytology report of Urine Cyto stain
18
77
2.43
2.88
3.1
2.4
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
6
9
6.79
2.88
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
6
9
6.79
2.88
1.0
1.0
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
241
2191
1.88
2.81
15.1
12.9
mmol/l
3.9
4.0
2.09
235
2134
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
52
332
1.70
2.79
3.1
2.4
e6/l
0.5
0.8
0.73
28
185
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
228
2042
1.72
2.77
4.5
4.0
mmol/l
5.6
5.8
2.47
216
1899
(3006270) Folate [Moles/volume] in Blood
6
10
6.11
2.71
1.2
1.2
nmol/l
312.8
437.7
—
6
10
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
41
250
1.75
2.59
4.3
3.8
%
35.3
30.9
1.41
33
173
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
93
696
1.51
2.57
3.4
3.1
ng/l
20.9
34.4
0.93
56
437
(3000012) Reticulocyte production index
5
7
7.25
2.56
1.4
2.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
6
11
5.55
2.55
1.7
3.0
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
49
316
1.67
2.54
1.5
1.8
pmol/l
335.8
434.6
2.84
38
269
(3002256) Pathology report gross observation
39
236
1.76
2.53
1.3
1.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
68
477
1.57
2.51
2.1
2.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
33
193
1.81
2.40
1.2
1.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
34
201
1.79
2.39
1.6
1.4
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
5
8
6.34
2.38
1.4
1.0
ug/l
7.7
8.2
—
5
8
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
56
380
1.60
2.37
1.5
1.6
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
12
47
2.62
2.30
1.2
1.1
—
—
—
0
0
(4094501)
13
54
2.48
2.23
1.2
1.1
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
62
438
1.54
2.21
3.0
2.5
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
12
49
2.52
2.13
1.0
1.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
82
619
1.46
2.12
2.4
2.3
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
137
1142
1.40
2.03
3.8
4.6
mmol/l
6.5
6.6
0.25
131
1057
(3019309) Folate [Moles/volume] in Red Blood Cells
47
318
1.58
2.02
1.7
1.6
nmol/l
908.2
1188.9
1.96
38
248
(3004588) Protein electrophoresis panel - Serum or Plasma
20
106
1.96
1.96
3.7
2.7
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
44
295
1.59
1.96
3.3
2.5
e6/l
5.4
1.4
0.39
21
149
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
233
2147
1.59
1.96
4.1
3.9
mmol/l
4.5
4.7
2.57
226
2019
(3022621) pH of Urine by Test strip
22
121
1.89
1.95
4.4
2.0
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
6
16
3.81
1.94
2.3
4.8
%
85.3
88.6
—
6
16
(3021601) Nitrite [Presence] in Urine by Test strip
119
974
1.39
1.94
6.2
4.0
estimate
0.0
0.0
0.00
17
189
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
94
739
1.42
1.93
4.7
4.4
ug/l
1.9
2.4
0.37
88
672
(36304419) Bacteria [Presence] in Urine
71
530
1.46
1.93
3.5
2.7
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
15
72
2.15
1.90
2.5
2.6
—
—
—
0
0
(4035726)
28
168
1.74
1.89
1.6
1.4
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
120
987
1.39
1.89
4.2
3.0
estimate
0.0
0.0
0.00
17
179
(3019150) Specific gravity of Urine by Refractometry
62
453
1.48
1.87
4.8
3.0
kg/l
1.0
1.0
0.54
20
62
(3026389) Candida sp identified in Specimen by Organism specific culture
6
17
3.58
1.84
1.3
1.2
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
91
717
1.40
1.83
2.3
1.8
pmol/l
95.3
98.2
0.28
59
393
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
87
681
1.41
1.82
3.7
2.9
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
15
76
2.03
1.68
1.7
1.4
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
6
19
3.20
1.67
1.2
1.4
—
—
—
0
0
(3018418) pH of Serum or Plasma
70
535
1.42
1.66
3.7
3.7
ph
7.4
7.4
0.35
13
105
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
12
56
2.20
1.63
1.2
1.6
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
247
2329
1.66
1.63
12.3
10.5
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
230
2139
1.49
1.57
4.2
3.8
mmol/l
1.4
1.4
0.09
222
2004
(3035350) Ketones [Presence] in Urine by Test strip
116
971
1.34
1.56
4.2
3.0
estimate
0.0
0.0
0.00
16
188
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
5
15
3.37
1.53
2.0
2.3
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
29
188
1.61
1.50
2.6
4.7
ug/l
2.7
28.6
0.61
19
157
(3024980) IgG subclass 4 [Mass/volume] in Serum
9
37
2.48
1.49
1.8
1.9
g/l
0.7
1.0
—
9
27
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
59
446
1.41
1.49
2.8
2.0
mg/l
2.8
3.1
0.50
50
399
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
5
16
3.16
1.44
1.2
1.2
—
—
—
0
0
(4062490)
6
22
2.76
1.44
2.5
1.3
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
69
540
1.37
1.42
3.5
2.8
e6/l
0.1
0.4
1.72
49
399
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
10
46
2.22
1.41
1.1
1.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
232
2173
1.46
1.40
4.5
4.2
mmol/l
2.6
2.8
2.58
223
2030
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
16
89
1.85
1.40
2.6
2.3
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
5
17
2.98
1.36
2.4
2.5
pg
34.8
33.8
—
5
17
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
12
61
2.01
1.35
1.3
1.4
u/ml
217.0
193.5
—
6
36
(3011397) Hemoglobin [Presence] in Urine by Test strip
58
445
1.39
1.34
4.5
3.1
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
8
34
2.39
1.30
5.9
5.6
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
47
350
1.41
1.29
1.2
1.3
u/ml
0.9
5.5
1.58
13
134
(3048929) Epstein Barr virus Ab [Presence] in Serum
16
92
1.79
1.28
1.3
1.5
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
8
35
2.32
1.28
1.5
2.1
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
6
25
2.43
1.25
1.3
2.0
nmol/l
1.8
2.9
—
6
25
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
12
63
1.95
1.25
1.3
1.4
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
11
56
2.00
1.24
1.2
1.6
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
39
283
1.44
1.23
1.9
2.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
43
318
1.42
1.23
2.0
2.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
75
608
1.32
1.22
3.5
4.1
%
24.6
22.2
0.59
36
286
(3037121) Protein [Mass/volume] in Urine
13
71
1.87
1.21
2.4
4.0
g/l
0.1
0.2
—
8
35
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
91
759
1.30
1.21
4.3
3.0
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
12
64
1.92
1.20
4.8
1.9
g/l
3.2
3.7
—
7
52
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
12
64
1.92
1.20
4.7
1.9
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
67
536
1.33
1.19
3.2
2.6
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
6
26
2.34
1.19
1.2
1.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
11
57
1.97
1.18
1.6
2.8
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
29
200
1.50
1.18
12.7
17.8
inr
1.5
1.3
—
6
32
(3021960) Folate [Moles/volume] in Serum or Plasma
55
428
1.36
1.17
1.5
1.5
nmol/l
15.2
20.0
2.64
46
375
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
13
72
1.85
1.17
1.2
1.9
—
192.0
—
0
5
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
8
39
2.08
1.16
1.1
1.2
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
0
36
0.00
1.15
0.0
5.3
—
361.5
—
0
31
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
36
0.00
1.15
0.0
1.6
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
220
2063
1.35
1.13
3.8
3.5
mmol/l
1.2
1.3
0.57
213
1928
(3015377) Calcium [Moles/volume] in Serum or Plasma
74
608
1.30
1.09
6.0
3.2
mmol/l
2.4
2.4
0.16
69
545
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
7
32
2.22
1.09
2.1
6.4
—
3404.6
—
0
8
(3026493) Urate [Moles/volume] in Serum or Plasma
63
507
1.32
1.08
3.4
2.7
umol/l
329.1
3297.1
1.31
56
449
(40760892) CBC W Ordered Manual Differential panel - Blood
62
498
1.32
1.07
4.3
5.1
—
—
—
0
0
(3003338) MCHC [Mass/volume]
210
1962
1.31
1.07
17.7
15.1
g/l
336.8
334.3
3.51
210
1956
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
7
33
2.15
1.06
1.1
1.3
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
48
372
1.35
1.06
1.2
1.3
iu/ml
27.0
35.7
0.25
14
109
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
56
445
1.33
1.05
2.4
2.8
ug/l
0.8
0.7
0.41
33
286
(3027135) IgG subclass 1 [Mass/volume] in Serum
5
22
2.30
1.04
2.2
1.3
g/l
6.0
6.9
—
5
14
(3024139) IgG subclass 3 [Mass/volume] in Serum
5
22
2.30
1.04
2.2
1.3
g/l
0.4
0.3
—
5
14
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
5
22
2.30
1.04
1.0
1.4
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
5
22
2.30
1.04
2.2
1.3
g/l
2.9
2.6
—
5
14
(3014051) Protein [Presence] in Urine by Test strip
7
36
1.97
0.97
2.1
1.4
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
20
134
1.53
0.95
3.5
3.5
kpa
5.1
5.2
0.19
20
125
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
105
915
1.24
0.94
3.6
3.9
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
19
126
1.55
0.94
3.6
3.6
mmol/l
2.8
1.5
1.40
13
100
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
6
27
2.25
0.94
1.0
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
18
119
1.55
0.90
1.2
1.2
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
23
161
1.47
0.90
3.2
3.3
mmol/l
1.7
2.1
0.23
14
121
(3012544) pH of Venous blood
23
161
1.47
0.90
3.3
3.5
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
11
64
1.75
0.87
1.3
2.0
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
8
44
1.84
0.86
1.5
1.3
pmol/l
78.4
300.5
—
8
44
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
15
96
1.60
0.86
1.6
1.9
u/l
39.7
41.5
0.14
15
87
(3022313) Gas panel - Capillary blood
15
96
1.60
0.86
3.6
3.8
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
6
31
1.96
0.85
2.8
3.0
umol/l
8.9
4.8
—
6
24
(1761482) Bacteria [#/volume] in Urine by Culture
6
32
1.89
0.82
4.7
3.7
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
43
343
1.30
0.80
1.6
2.0
%
1.4
1.4
0.07
38
315
(1002224) Polysomnography panel
18
123
1.50
0.80
1.1
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
12
74
1.65
0.79
1.4
1.6
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
6
33
1.84
0.79
1.2
2.1
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
60
500
1.26
0.79
4.7
4.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
11
67
1.67
0.76
1.1
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
8
136
0.58
0.75
1.1
1.3
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
5
24
2.10
0.75
1.2
1.3
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
13
84
1.58
0.73
1.5
1.3
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
5
25
2.02
0.73
5.4
4.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
35
276
1.31
0.71
1.5
1.5
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
7
42
1.68
0.69
2.6
1.7
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
5
27
1.87
0.69
1.4
1.3
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
5
27
1.87
0.69
1.2
1.2
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
5
28
1.80
0.66
3.4
2.1
mmol/l
7.5
7.2
—
5
28
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13
189
0.67
0.66
2.8
2.9
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
7
44
1.61
0.65
1.4
1.3
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
61
522
1.22
0.64
1.6
1.7
mmol/l
1.3
1.4
0.61
53
449
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
5
29
1.74
0.64
1.2
1.2
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
5
29
1.74
0.64
3.4
2.1
mmol/l
1.3
1.4
—
5
29
(3019230) Fractional oxyhemoglobin in Venous blood
5
29
1.74
0.64
4.6
2.0
%
72.3
67.9
—
5
29
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
11
71
1.57
0.63
2.2
3.1
u/ml
9.1
111.7
0.85
11
60
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
0
20
0.00
0.60
0.0
3.3
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
0
20
0.00
0.60
0.0
1.4
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
8.6
—
0.6
—
0
21
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
21
0.00
0.60
0.0
1.8
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
15
106
1.44
0.59
1.8
1.7
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
6
36
1.68
0.57
1.2
1.1
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
15
107
1.43
0.56
8.5
4.9
mmol/l
23.7
25.2
1.21
15
107
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
8
55
1.47
0.56
1.4
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
10
65
1.56
0.56
1.3
1.2
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
39
324
1.24
0.55
3.2
2.9
mmol/l
2.4
2.4
1.32
39
288
(40768443) Skin Pathology biopsy report
11
74
1.51
0.54
1.3
1.2
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
6
39
1.55
0.53
1.0
1.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
6
40
1.51
0.52
1.2
1.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
6
40
1.51
0.52
1.0
1.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
31
253
1.25
0.51
1.3
1.5
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
216
2083
1.18
0.49
16.3
12.3
%
41.2
41.2
0.04
173
1626
(3008152) Bicarbonate [Moles/volume] in Arterial blood
8
118
0.67
0.47
4.1
10.4
mmol/l
24.8
24.3
—
8
112
(3019060) Gas panel - Arterial blood
8
120
0.66
0.46
2.9
7.5
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
103
948
1.14
0.45
9.5
8.6
e9/l
0.0
0.0
0.50
80
760
(3026782) Osmolality of Urine
41
351
1.20
0.44
2.4
2.4
mosm/kgh2o
585.3
592.9
0.06
35
293
(3024928) Oxygen saturation in Venous blood
5
31
1.62
0.43
4.6
3.8
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
8
57
1.42
0.42
1.6
1.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
5
33
1.52
0.41
1.6
1.3
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
20
159
1.28
0.41
3.4
5.5
%
0.1
0.2
—
7
54
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
16
123
1.32
0.41
1.3
1.5
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
5
34
1.48
0.40
1.0
1.0
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
21
169
1.26
0.40
3.4
5.3
%
1.3
1.0
—
7
63
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
8
61
1.32
0.40
1.4
1.7
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
19
151
1.28
0.39
3.4
5.5
%
0.1
0.0
—
7
47
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
15
115
1.32
0.39
1.1
1.0
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
11
80
1.39
0.39
1.4
2.3
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
5
36
1.40
0.38
2.8
3.9
%
58.2
55.4
—
5
36
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
9
68
1.33
0.38
1.4
1.9
pmol/l
224.6
251.2
—
9
63
(40758558) Short blood count panel - Blood
57
510
1.15
0.38
12.5
7.3
—
—
—
0
0
(3036489) Thrombin time
10
73
1.38
0.35
3.4
2.6
s
21.6
21.7
—
10
66
(4010399)
19
154
1.25
0.35
1.4
1.5
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
6
45
1.34
0.34
6.7
1.4
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
6
45
1.34
0.34
1.3
1.3
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
6
47
1.28
0.32
4.0
2.5
mmol/l
25.2
25.1
—
6
39
(21494755) Public health laboratory ask at order entry panel
26
304
0.84
0.32
1.3
1.4
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
7
55
1.28
0.30
2.4
1.9
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
17
139
1.24
0.29
1.6
1.2
iu/ml
27.7
130.6
—
7
62
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
7
56
1.26
0.29
1.7
1.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
8
109
0.73
0.29
1.0
1.1
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
33
290
1.16
0.28
1.6
1.8
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
8
63
1.28
0.28
1.3
1.4
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
5
71
0.70
0.26
1.0
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
5
72
0.69
0.26
1.0
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
5
72
0.69
0.26
1.0
1.2
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
5
74
0.67
0.26
2.0
1.4
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
9
72
1.26
0.26
1.1
1.3
—
—
—
0
0
(3020891) Body temperature
6
82
0.73
0.24
3.5
3.5
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
29
257
1.14
0.23
1.8
1.7
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
5
39
1.29
0.23
1.2
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
88
832
1.09
0.23
2.4
2.3
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
10
79
1.28
0.22
10.8
11.8
mmol/l
24.0
24.3
—
10
73
(3028433) Virus identified in Specimen by Culture
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
12
0.00
0.21
0.0
6.8
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
12
0.00
0.21
0.0
1.0
—
7.9
—
0
12
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
32
288
1.13
0.21
1.8
2.2
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
14
117
1.21
0.21
1.5
1.4
—
—
—
0
0
(4027681)
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
0
14
0.00
0.20
0.0
2.4
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
6
52
1.16
0.19
1.0
1.6
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
6
52
1.16
0.19
1.7
1.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
63
592
1.08
0.19
1.4
1.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
22
248
0.88
0.19
1.6
1.7
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
6
53
1.13
0.19
5.8
3.2
kpa
9.2
8.5
—
6
48
(3016879) Cocaine [Presence] in Urine
11
132
0.83
0.18
1.3
2.0
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
53
495
1.09
0.18
3.1
3.1
mg/l
24.9
308.8
0.92
36
329
(3001019) Free T4 and TSH panel - Serum or Plasma
13
110
1.19
0.17
1.3
1.6
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
55
516
1.08
0.17
3.5
3.8
mg/mmol
4.2
7.6
0.76
39
336
(3028707) Methadone [Presence] in Urine by Screen method
5
68
0.73
0.17
1.2
2.5
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
8
72
1.11
0.16
1.5
1.6
—
—
—
0
0
(4034850)
8
72
1.11
0.16
9.6
9.9
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
50
471
1.08
0.14
1.8
2.0
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
10
118
0.84
0.14
11.0
9.1
%
0.7
0.7
—
10
118
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
18
160
1.13
0.14
1.7
2.0
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
15
170
0.88
0.14
7.8
9.6
g/l
132.5
125.3
0.42
15
164
(3000492) Spirometry study
22
242
0.90
0.13
1.4
1.5
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
13
113
1.16
0.13
1.2
2.0
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
37
347
1.08
0.12
3.5
3.2
ng/l
13.2
284.6
2.48
26
236
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
197
1943
1.05
0.11
5.4
4.7
mmol/mol
37.6
38.7
0.79
187
1830
(3011288) Drugs identified in Urine by Screen method
11
96
1.15
0.10
2.8
2.3
—
—
—
0
0
(3000991) Gas panel - Venous blood
17
154
1.11
0.10
7.4
8.4
—
—
—
0
0
(40768793) Breast Pathology biopsy report
5
47
1.07
0.09
1.4
1.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
22
237
0.92
0.09
6.4
6.8
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
6
58
1.04
0.08
1.2
1.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
30
283
1.07
0.08
1.6
1.4
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
9
103
0.87
0.06
1.6
1.6
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
9
104
0.86
0.06
2.1
1.6
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
17
158
1.08
0.06
2.2
2.8
ml/min/173m2
67.2
72.1
—
5
63
(40761536) Microorganisms panel - Urine sediment
15
161
0.93
0.05
2.4
3.3
—
—
—
0
0
(3044889) 12 lead EKG panel
144
1423
1.03
0.05
3.5
3.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
27
258
1.05
0.05
1.7
1.6
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
15
141
1.07
0.03
1.2
1.9
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
11
118
0.93
0.03
10.1
9.1
%
1.3
1.7
0.86
11
118
(3028300) Cannabinoids [Presence] in Urine
15
142
1.06
0.02
1.2
1.9
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
15
142
1.06
0.02
1.2
1.9
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
15
142
1.06
0.02
1.2
1.9
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
54
533
1.02
0.01
4.1
3.2
estimate
0.0
0.0
0.50
17
183
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
11
104
1.06
0.01
1.2
1.5
mg/l
1.0
3.3
—
6
73
(3014007) Fractional oxyhemoglobin in Arterial blood
11
116
0.95
0.00
10.1
9.3
%
96.2
93.5
3.14
11
116
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
17
176
0.96
0.00
1.6
1.4
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
22
214
1.03
0.00
1.7
1.7
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
23
232
0.99
0.00
1.5
1.8
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
13
133
0.98
0.00
1.7
1.9
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
22
217
1.02
0.00
1.8
1.8
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
60
595
1.01
0.00
2.9
2.9
mmol/l
8.9
8.7
0.10
53
505
(40761535) Cells panel - Urine sediment
16
165
0.97
0.00
3.9
3.1
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
23
225
1.02
0.00
6.0
6.2
mmol/l
105.1
104.3
0.34
23
220
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
0
5
0.00
0.00
0.0
2.8
—
6.8
—
0
5
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3022229) Phosphate [Moles/volume] in Urine
0
5
0.00
0.00
0.0
2.2
—
23.1
—
0
5
(3042733) HLA Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.6
—
1.2
—
0
5
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
0
5
0.00
0.00
0.0
4.2
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
13.7
—
0
5
(3009871) Measles virus Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
19.6
—
0
5
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
0
5
0.00
0.00
0.0
7.6
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
0
5
0.00
0.00
0.0
2.8
—
3.4
—
0
5
(3024932) HLA-DR beta [Type]
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
8
82
0.97
0.00
11.4
17.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
12
120
1.00
0.00
1.3
1.2
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024263) Appearance of Synovial fluid
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
8
80
1.00
0.00
4.0
2.5
%
37.8
51.2
—
8
80
(3004451) EKG impression Narrative
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
6
63
0.95
0.00
2.7
3.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
5
52
0.96
0.00
1.2
14.2
mmol/l
2.0
1.2
—
5
45
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
0
9
0.00
0.00
0.0
1.1
—
94.0
—
0
9
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
0
7
0.00
0.00
0.0
2.1
—
139.8
—
0
7
(3005011) Chlamydia sp Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3035880) pH of Pleural fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint E4_GILBERT and mortality.
Females
No dataMales
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| E4_GILBERT | 1.128 [0.89, 1.43] | 0.317 |
| Birth year | 0.984 [0.97, 0.99] | 0.002 |
During the follow-up period (1.1.1998 — 31.12.2019), 100 out of 970 males with E4_GILBERT died.
Mortality risk
Mortality risk for people of age
years, who have E4_GILBERT.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | 0.198% |
| 5 | No data | 1.228% |
| 10 | No data | 3.072% |
| 15 | No data | 5.6% |
| 20 | No data | 9.732% |
Relationships between endpoints
↥Index endpoint: E4_GILBERT – Gilbert syndrome
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data